Lilly M P, Slafsky S F, Thompson W R
Arch Surg. 1984 Jul;119(7):849-53. doi: 10.1001/archsurg.1984.01390190087020.
Despite a paucity of published clinical trials, use of the Angelchik antireflux prosthesis has increased dramatically since its introduction in 1979. Serious complications of this device have begun to appear. We dealt with two cases of erosion of the prosthesis into the gastrointestinal tract, one of which represents, to our knowledge, the first reported case of a gastroenteric fistula secondary to the device. Other complications of the use of this prosthesis have appeared in the literature. Carefully controlled clinical studies with long-term follow-up are needed to assess the overall benefits and safety of this new antireflux prosthesis.
尽管已发表的临床试验较少，但自1979年引入Angelchik抗反流假体以来，其使用量急剧增加。该装置的严重并发症已开始出现。我们处理了两例假体侵蚀至胃肠道的病例，据我们所知，其中一例是该装置继发胃肠瘘的首例报道病例。关于该假体使用的其他并发症也已见诸文献。需要进行长期随访的严格对照临床研究，以评估这种新型抗反流假体的总体益处和安全性。
